METTL1 and invasive breast carcinoma: Several studies have revealed upregulated expression of METTL1 in other tumors, including invasive breast carcinoma (BRCA), kidney renal clear cell carcinoma (KIRC), prostate adenocarcinoma, rectal carcinoma, and uterine corpus endometrial carcinoma [55, 56, 81, 82].